These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma. Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754 [TBL] [Abstract][Full Text] [Related]
23. [Surgical resection of pancreatic adenocarcinoma: indications and contraindications, pronostic factors and survival, recent advances]. Delpero JR Cancer Radiother; 2004 Nov; 8 Suppl 1():S73-9. PubMed ID: 15679251 [TBL] [Abstract][Full Text] [Related]
24. [Pancreatic carcinoma--conclusions and prospects]. Trede M; Wendl K; Richter A Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():411-20. PubMed ID: 9931651 [TBL] [Abstract][Full Text] [Related]
25. [Surgical treatment of carcinoma of the pancreas]. Doi R; Kami K; Ito D; Kawaguchi Y; Uemoto S; Yoshida S Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):168-72. PubMed ID: 16878408 [TBL] [Abstract][Full Text] [Related]
28. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662 [TBL] [Abstract][Full Text] [Related]
32. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937 [TBL] [Abstract][Full Text] [Related]
33. [Carcinoma of the pancreas: current status of multimodal therapy]. Keck T Zentralbl Chir; 2011 Aug; 136(4):352-8. PubMed ID: 21773958 [TBL] [Abstract][Full Text] [Related]
34. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190 [TBL] [Abstract][Full Text] [Related]
35. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141 [TBL] [Abstract][Full Text] [Related]
36. Effect of different treatment methods on survival in patients with pancreatic cancer. Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944 [TBL] [Abstract][Full Text] [Related]
38. [Surgical standard therapy for cancer of the pancreas]. Friess H; Kleeff J; Fischer L; Müller M; Büchler MW Chirurg; 2003 Mar; 74(3):183-90. PubMed ID: 12647074 [TBL] [Abstract][Full Text] [Related]
39. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute. Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic carcinoma: < or = 2 cm versus > 2 cm in size. Yamaguchi K; Mizumoto K; Noshiro H; Sugitani A; Shimizu S; Chijiiwa K; Tanaka M Int Surg; 1999; 84(3):213-9. PubMed ID: 10533779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]